Omega Healthcare Investors (BSP:O2HI34) Enterprise Value: R$97,693 Mil (As of Jun. 25, 2026) ***


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$62.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Enterprise Value?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 Enterprise Value is R$97,693 Mil as of Jun. 25, 2026. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$62.11 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Omega Healthcare Investors's Enterprise Value is R$97,693 Mil. Omega Healthcare Investors's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was R$4,761 Mil. Therefore, Omega Healthcare Investors's EV-to-EBIT ratio for today is 20.52.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Omega Healthcare Investors's Enterprise Value is R$97,693 Mil. Omega Healthcare Investors's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was R$6,539 Mil. Therefore, Omega Healthcare Investors's EV-to-EBITDA ratio for today is 14.94.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Omega Healthcare Investors's Enterprise Value is R$97,693 Mil. Omega Healthcare Investors's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was R$6,668 Mil. Therefore, Omega Healthcare Investors's EV-to-Revenue ratio for today is 14.65.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Omega Healthcare Investors's Enterprise Value is R$97,693 Mil. Omega Healthcare Investors's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was R$4,928 Mil. Therefore, Omega Healthcare Investors's EV-to-OCF ratio for today is 19.82.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Omega Healthcare Investors's Enterprise Value is R$97,693 Mil. Omega Healthcare Investors's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was R$4,928 Mil. Therefore, Omega Healthcare Investors's EV-to-FCF ratio for today is 19.82.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Omega Healthcare Investors  (BSP:O2HI34) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Omega Healthcare Investors's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=97693.031/4760.885
=20.52

Omega Healthcare Investors's current Enterprise Value is R$97,693 Mil.
Omega Healthcare Investors's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4,761 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Omega Healthcare Investors's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=97693.031/6539.221
=14.94

Omega Healthcare Investors's current Enterprise Value is R$97,693 Mil.
Omega Healthcare Investors's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$6,539 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Omega Healthcare Investors's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=97693.031/6668.262
=14.65

Omega Healthcare Investors's current Enterprise Value is R$97,693 Mil.
Omega Healthcare Investors's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$6,668 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Omega Healthcare Investors's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=97693.031/4927.966
=19.82

Omega Healthcare Investors's current Enterprise Value is R$97,693 Mil.
Omega Healthcare Investors's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4,928 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Omega Healthcare Investors's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=97693.031/4927.966
=19.82

Omega Healthcare Investors's current Enterprise Value is R$97,693 Mil.
Omega Healthcare Investors's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4,928 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omega Healthcare Investors Enterprise Value Related Terms


Omega Healthcare Investors Enterprise Value Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Enterprise Value Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSP:O2HI34 vs DOC, AHR, CTRE: Enterprise Value Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors Enterprise Value vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's Enterprise Value falls into.


BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Omega Healthcare Investors's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Omega Healthcare Investors's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of R$97,693 Mil mean?
Omega Healthcare Investors (BSP:O2HI34) has a Enterprise Value of R$97,693 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Omega Healthcare Investors and its competitors.
Is Omega Healthcare Investors' Enterprise Value too high?
Omega Healthcare Investors' current Enterprise Value is R$97,693 Mil. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Enterprise Value compare to DOC and AHR?
Omega Healthcare Investors' Enterprise Value of R$97,693 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a REITs company?
A good Enterprise Value depends on the REITs industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Omega Healthcare Investors and its competitors. Omega Healthcare Investors's current Enterprise Value is R$97,693 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$62.11, compared to a current price of R$77.02 — trading 24% above its estimated fair value. The current Enterprise Value is R$97,693 Mil. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Enterprise Value is R$97,693 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 24% above its estimated GF Value™ of R$62.11. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Enterprise Value: R$97,693 Mil
  • GF Value™: R$62.11 vs. price of R$77.02 (24% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$62.11
GF Value